Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 5.99
(2.92%)
CNY 5.99
(2.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 519.14 Million CNY | 6.53% |
| 2022 | 393.12 Million CNY | -3.13% |
| 2021 | 405.82 Million CNY | 2.97% |
| 2020 | 394.11 Million CNY | 7.73% |
| 2019 | 365.84 Million CNY | 44.44% |
| 2018 | 253.28 Million CNY | 17.81% |
| 2017 | 214.99 Million CNY | -14.36% |
| 2016 | 251.04 Million CNY | 0.34% |
| 2015 | 250.18 Million CNY | 18.63% |
| 2014 | 210.89 Million CNY | 28.65% |
| 2013 | 163.92 Million CNY | 19.84% |
| 2012 | 136.79 Million CNY | 29.63% |
| 2011 | 105.52 Million CNY | 67.32% |
| 2010 | 63.06 Million CNY | 26.37% |
| 2009 | 49.9 Million CNY | 15.89% |
| 2008 | 43.06 Million CNY | 57.85% |
| 2007 | 27.28 Million CNY | 3.76% |
| 2006 | 26.29 Million CNY | 5.36% |
| 2005 | 24.95 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 97.86 Million CNY | 16.46% |
| 2024 Q3 | 105.61 Million CNY | 25.15% |
| 2024 Q1 | 84.03 Million CNY | -30.23% |
| 2023 Q3 | 102.59 Million CNY | -18.71% |
| 2023 Q4 | 120.44 Million CNY | 17.39% |
| 2023 FY | 418.8 Million CNY | 6.53% |
| 2023 Q1 | 69.54 Million CNY | -41.67% |
| 2023 Q2 | 126.22 Million CNY | 81.5% |
| 2022 Q3 | 111.59 Million CNY | 16.67% |
| 2022 FY | 393.12 Million CNY | -3.13% |
| 2022 Q2 | 95.65 Million CNY | 43.51% |
| 2022 Q4 | 119.22 Million CNY | 6.84% |
| 2022 Q1 | 66.64 Million CNY | -41.44% |
| 2021 Q2 | 120.35 Million CNY | 43.56% |
| 2021 Q1 | 83.83 Million CNY | -37.03% |
| 2021 Q4 | 113.81 Million CNY | 29.61% |
| 2021 Q3 | 87.81 Million CNY | -27.04% |
| 2021 FY | 405.82 Million CNY | 2.97% |
| 2020 FY | 394.11 Million CNY | 7.73% |
| 2020 Q2 | 96.56 Million CNY | 58.32% |
| 2020 Q3 | 103.41 Million CNY | 7.1% |
| 2020 Q4 | 133.14 Million CNY | 28.74% |
| 2020 Q1 | 60.99 Million CNY | -49.86% |
| 2019 Q2 | 86.96 Million CNY | 19.89% |
| 2019 FY | 365.84 Million CNY | 44.44% |
| 2019 Q4 | 121.64 Million CNY | 43.63% |
| 2019 Q3 | 84.69 Million CNY | -2.61% |
| 2019 Q1 | 72.53 Million CNY | -12.03% |
| 2018 FY | 253.28 Million CNY | 17.81% |
| 2018 Q3 | 60.3 Million CNY | -1.18% |
| 2018 Q1 | 49.5 Million CNY | -18.5% |
| 2018 Q4 | 82.45 Million CNY | 36.74% |
| 2018 Q2 | 61.02 Million CNY | 23.27% |
| 2017 Q4 | 60.73 Million CNY | 7.83% |
| 2017 FY | 214.99 Million CNY | -14.36% |
| 2017 Q2 | 52.39 Million CNY | 15.07% |
| 2017 Q1 | 45.53 Million CNY | -30.28% |
| 2017 Q3 | 56.32 Million CNY | 7.51% |
| 2016 Q1 | 58.71 Million CNY | -0.06% |
| 2016 Q3 | 60.6 Million CNY | -8.76% |
| 2016 Q2 | 66.41 Million CNY | 13.12% |
| 2016 Q4 | 65.3 Million CNY | 7.77% |
| 2016 FY | 251.04 Million CNY | 0.34% |
| 2015 Q3 | 62.75 Million CNY | -11.77% |
| 2015 FY | 250.18 Million CNY | 18.63% |
| 2015 Q2 | 71.12 Million CNY | 23.58% |
| 2015 Q4 | 58.75 Million CNY | -6.38% |
| 2015 Q1 | 57.55 Million CNY | -20.3% |
| 2014 Q4 | 72.2 Million CNY | 35.51% |
| 2014 Q1 | 37.69 Million CNY | -26.38% |
| 2014 Q2 | 47.71 Million CNY | 26.59% |
| 2014 FY | 210.89 Million CNY | 28.65% |
| 2014 Q3 | 53.28 Million CNY | 11.68% |
| 2013 FY | 163.92 Million CNY | 19.84% |
| 2013 Q4 | 51.19 Million CNY | 20.61% |
| 2013 Q1 | 32.34 Million CNY | -17.09% |
| 2013 Q2 | 37.94 Million CNY | 17.3% |
| 2013 Q3 | 42.44 Million CNY | 11.87% |
| 2012 Q3 | 35.72 Million CNY | 11.24% |
| 2012 FY | 136.79 Million CNY | 29.63% |
| 2012 Q4 | 39.01 Million CNY | 9.2% |
| 2012 Q2 | 32.11 Million CNY | 7.29% |
| 2012 Q1 | 29.93 Million CNY | -10.62% |
| 2011 Q3 | 26.2 Million CNY | -2.9% |
| 2011 Q2 | 26.98 Million CNY | 43.23% |
| 2011 FY | 105.52 Million CNY | 67.32% |
| 2011 Q1 | 18.84 Million CNY | -11.69% |
| 2011 Q4 | 33.49 Million CNY | 27.81% |
| 2010 Q1 | 11.39 Million CNY | -24.38% |
| 2010 Q2 | 15.14 Million CNY | 32.91% |
| 2010 Q3 | 15.18 Million CNY | 0.27% |
| 2010 FY | 63.06 Million CNY | 26.37% |
| 2010 Q4 | 21.33 Million CNY | 40.49% |
| 2009 Q4 | 15.06 Million CNY | 13.6% |
| 2009 Q2 | 9.91 Million CNY | -14.87% |
| 2009 Q1 | 11.65 Million CNY | -20.6% |
| 2009 FY | 49.9 Million CNY | 15.89% |
| 2009 Q3 | 13.26 Million CNY | 33.74% |
| 2008 Q3 | 11.23 Million CNY | 0.0% |
| 2008 Q4 | 14.67 Million CNY | 30.65% |
| 2008 FY | 43.06 Million CNY | 57.85% |
| 2007 FY | 27.28 Million CNY | 3.76% |
| 2006 FY | 26.29 Million CNY | 5.36% |
| 2005 FY | 24.95 Million CNY | 0.0% |